Pharmacy (PHRM)

496. Topics in Pharmacy. (1 to a maximum of 3 Δ)


497. Problems in Pharmacy. (1-5, no limit Δ)


498. Problems in Pharmacy. (1-5, no limit Δ)


507 / 707. Pharmacy and Health Care Delivery. (3)


511 / 773. Nuclear Pharmacy Instrumentation. (3)


512 / 774. Radiopharmaceutical Chemistry. (1)


513 / 775. Radiation Biology and Radiation Safety. (3)


516 / 776. Radiopharmacology. (3)


521. Radiopharmaceutics. (2)


523. Clinical Nuclear Medicine. (1)


528 / 728. Pharmacoepidemiology and Biomedical Literature Evaluation. (3)


535. Supplementary Training in Pharmaceutical Sciences. (1)


536 / 736. Introduction to Pharmacogenomics. (2)


545. Pharmacoeconomics. (3)


546. Healthcare Systems Review. (3)


547. Research Design and Analysis. (3)


548. Ethics Clinical Trials-Informed Consent. (2)


549. Regulatory Issues in Clinical Trials. (2)


551. Fundamentals of Clinical Trials. (3)


560 / 760. Pharmacy Healthcare Management and Economics. (3)


566 / 766. Public Health in Pharmacy. (2)


576. Molecular and Cellular Pharmacology. (3 [1])


580. General Toxicology. (3 [2])


591. Seminar in Administrative Pharmacy. (1, no limit Δ)


592. Seminar in Radiopharmacy. (1, no limit Δ)


593. Pharmaceutical Sciences and Toxicology Seminar. (1, no limit Δ)


594. Topics in Environmental Disease. (1-3 to a maximum of 4 Δ)


597. Research Problems in Pharmaceutical Sciences. (1-6, no limit Δ)


598. Topics in Pharmaceutical Sciences. (1-3 to a maximum of 4 Δ)


599. Master's Thesis. (1-6, no limit Δ)


699. Dissertation. (1-9 to a maximum of 18 Δ)


701. Pharmaceutics I. (3)


702. Pharmaceutics II. (3)


703L. Pharmaceutical Care Lab I. (3)


704L. Pharmaceutical Care Lab II. (3)


705. Pathophysiology. (4)


706. Foundations of Drug Action. (3)


707 / 507. Pharmacy and Health Care Delivery. (3)


709. Introduction to Pharmacy Practice. (1)


710. Mechanisms of Drug Action I. (5)


713. Pharmaceutical Calculations. (1)


715. Pathophysiology II. (4)


717. Introductory Pharmacy Law. (1)


718L. Pharmaceutical Care Lab III. (2)


719. Self-Care Therapeutics. (2)


720. Introduction to Nuclear Pharmacy. (2)


721. Self-Care Therapeutics II. (1)


726. Pharmacokinetics and Biopharmaceutics. (3)


728 / 528. Pharmacoepidemiology and Biomedical Literature Evaluation. (3)


731. Mechanisms of Drug Action II. (5)


732. Mechanisms of Drug Action III. (5)


733L. Pharmaceutical Care Lab IV. (2)


735. Substance Abuse Elective. (2)


736 / 536. Introduction to Pharmacogenomics. (2)


737. Introductory Spanish in the Pharmacy. (1)


738. Intermediate Spanish in the Pharmacy. (1)


739. Pharmacotherapy I. (6)


740. Self-Selected Supplementary Pharmacy Education. (1-2 to a maximum of 2 Δ)


748. Research Project (Initial). (1)


751. Pharmacotherapy II. (6)


752. Pharmacotherapy III. (6)


755. Seminar in Pharmacy. (1 to a maximum of 2 Δ)


756. Safe Medication Practices. (2)


758. Research Project. (1)


759. Advanced Law and Ethics. (2)


760 / 560. Pharmacy Healthcare Management and Economics. (3)


761. Introduction to Managed Care Pharmacy Practice. (2)


762L. Pharmaceutical Care Lab V. (2)


764. Emerging Technologies in Pharmaceutical Care. (1)


765L. Pharmaceutical Care Lab VI. (2)


766 / 566. Public Health in Pharmacy. (2)


769. Pharmacy Practice Experience. (0-4, may be repeated four times Δ)


770. Advanced Pharmacy Practice Experience. (2-4 to a maximum of 36 Δ)


771. Introductory Community Pharmacy Practice Experience. (4)


772. Introductory Institutional Pharmacy Practice Experience. (4)


773 / 511. Nuclear Pharmacy Instrumentation. (3)


774 / 512. Radiopharmaceutical Chemistry. (1)


775 / 513. Radiation Biology and Radiation Safety. (3)


776 / 516. Radiopharmacology. (3)


781. Geriatric Medication Management - An Interprofessional Elective. (2)


782. Clinical Toxicology. (2)


784. Advanced Infectious Diseases Pharmacotherapy. (1)


785. Advanced Cardiovascular Pharmacotherapy. (1)


786. Geriatric Interprofessional Elective. (2)


790. Physical Assessment for the Pharmacist. (2)


798. Problems in Pharmacy. (1-5 to a maximum of 10 Δ)


801. Applied Biochemistry. (3)


802. Physical Pharmacy and Biopharmaceutics. (3)


803. Aspects of Patient Care I. (3)


804. Public Health. (2)


805. Fundamentals of Pathophysiology and Immunology. (3)


807. Introduction to Pharmacy Practice and Communication. (2)


809. Pharmacy and Health Care Delivery Systems. (3)


810. Fundamentals of Pharmacokinetics and Dosage Forms. (3)


811. Introduction to Pharmacology and Medicinal Chemistry. (4)


813. Aspects of Patient Care II. (1)


815. Integrated Pharmacotherapeutics and Self Care. (4)


817. Introduction to Law, Ethics and Social Issues in Pharmacy. (2)


819. Professional Development I. (1)


820. Integrated Pharmacotherapeutics I. (3)


823. Aspects of Patient Care III. (2)


824. Dosage Forms. (3)


825. Integrated Pharmacotherapeutics II. (2)


828. Pharmacoepidemiology and Research Design. (2)


829. Professional Development II. (1)


830. Integrated Pharmacotherapeutics III. (3)


832. Evidence-Based Clinical Decision Making. (2)


833. Aspects of Patient Care IV. (2)


835. Integrated Pharmacotherapeutics IV. (3)


836. Pharmacoeconomics. (2)


837. Pharmacy Management and Operations. (3)


839. Professional Development III. (1)


840. Integrated Pharmacotherapeutics V. (2)


842. Safe Medications and Pharmacy Informatics. (3)


843. Aspects of Patient Care V. (2)


845. Integrated Pharmacotherapeutics VI. (4)


847. Integrated Pharmacotherapeutics VII. (2)


849. Professional Development IV. (1)


850. Integrated Pharmacotherapeutics VIII. (3)


851. Emerging Trends in Pharmacy. (1)


853. Aspects of Patient Care VI. (2)


854. Advanced Law and Ethics. (2)


855. Clinical Capstone. (5)


859. Professional Development V. (1)


Course Search:




Keyword Search:

Office of the Registrar

MSC 11 6325
1 University of New Mexico
Albuquerque, NM 87131

Phone: (505) 277-8900
Fax: (505) 277-6809